Insider Title Company Date Price Return Shares Value
Kaplan Matthew L. Non-Executive Director Nuvectis Pharma, Inc. (NVCT) 2025-11-05 $5.84 0.0% 11,000 $64,240
Kaplan Matthew L. Non-Executive Director Nuvectis Pharma, Inc. (NVCT) 2022-05-12 $16.88 -63.5% 3,000 $50,633
Return Profit / (loss) Cost
Total -28.0% $-32,153 $114,873